or search on
|Title:||The renewal of the National Cervical Screening Program.|
|Authors:||Carter J; Hammond I; Smith MA|
|Categories:||Early Detection, Diagnosis, and Prognosis - Technology and/or Marker Testing in a Clinical Setting|
Cancer Type - Cervical Cancer
|Journal Title:||Medical Journal of Australia|
|Abstract:||The renewed National Cervical Screening Program (NCSP) will use 5-yearly oncogenic human papillomavirus (HPV) testing and partial genotyping with reflex liquid-based cytology. There is overwhelming evidence from prospective randomised trials that primary HPV screening is vastly superior to cytology testing alone.1,2 The renewal is based on recommendations of the Australian Medical Services Advisory Committee (MSAC) following a robust and transparent process involving a commissioned evidence review and health outcome and economic modelling.3|
|Division:||Cancer Research Division|
|Appears in Collections:||Research Articles|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.